End-stage renal disease in a bodybuilder: A multifactorial process or simply doping?

Nephrology Dialysis Transplantation

Volumn 16, Issue 1, 2001, Pages 163-165

  Hartung, Roger ^a,c   Gerth, Jens ^a   Funfstück, Reinhard ^a   Gröne, Hermann Josef ^b   Stein, Günter ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c NONE   (Germany)

Author keywords

Anabolic androgen steroids; Bodybuilder; Clenbuterol; End stage renal disease; High protein diet; Hypertensive nephrosclerosis

Indexed keywords

ANABOLIC AGENT; ANALGESIC AGENT; CLENBUTEROL; CYCLOSPORIN; DEPOT ROTEX MEDICA; DIURETIC AGENT; LAXATIVE; MABUTEROL; NONSTEROID ANTIINFLAMMATORY AGENT; SEX HORMONE;

ACUTE HEART INFARCTION; ADULT; AFFECTIVE NEUROSIS; ARTICLE; ATHEROGENESIS; BODY BUILDING; CASE REPORT; CLINICAL FEATURE; CORONARY RISK; DOPING; ECHOGRAPHY; ELECTROCARDIOGRAM; EXERCISE; HEMATURIA; HUMAN; KIDNEY BIOPSY; KIDNEY FAILURE; LIVER FUNCTION; MALE; MUSCLE GROWTH; OBSTRUCTIVE JAUNDICE; PHYSICAL EXAMINATION; PHYSICAL PERFORMANCE; PRIORITY JOURNAL; PSYCHOSIS; RHABDOMYOLYSIS; STRENGTH; SYNCOPE; THORAX RADIOGRAPHY; UREMIA;

EID: 0035164819     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/16.1.163     Document Type: Article

References (10)

1. Changes in tissue blood flow and beta-receptor density of skeletal muscle in rats treated with the beta2-adrenoceptor agonist clenbuterol
2. The role of beta 2-adrenoceptor on the pathogenesis of insulin resistance in essential hypertension
3. Beneficial effect of low-dose treatment with a combination of moxonidine and nifedipine on glomerulosclerosis in experimental hypertension
4. The clinical diagnosis of hypertensive nephrosclerosis-how reliable is it?
5. 2-adrenoreceptor stimulant
6. Papillary necrosis in a ballet dancer with no history of analgesic abuse
7. Effects of testosterone on glomerular growth after uninephrectomy
8. Renal function and renal disease in males or females-vive la petite différence